| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (MGH 10 + methicillin-resistant) |
- |
- |
4 － ? |
Linezolid (PNU-100766, U-100766, Zyvox)  |
269 |
| Staphylococcus aureus (MGH 10 + methicillin-resistant) |
- |
- |
32 － ? |
Nafcillin (Unipen, Nafcil) |
269 |
| Staphylococcus aureus (mice) |
- |
- |
0.13 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
434 |
| Staphylococcus aureus (ML 123) |
- |
- |
1 － ? |
Gentamicin (Gentamycin, Garamycin) |
347 |
| Staphylococcus aureus (ML 123) |
- |
- |
256 － ? |
Mallotus peltatus leaf (Fraction A) |
347 |
| Staphylococcus aureus (ML 123) |
- |
- |
256 － ? |
Mallotus peltatus leaf (Methanol extract) |
347 |
| Staphylococcus aureus (ML 123) |
- |
- |
512 － ? |
Mallotus peltatus leaf (Fraction B) |
347 |
| Staphylococcus aureus (ML 267) |
- |
- |
10 － ? |
Coccinia grandis leaf (Methanol extract) |
682 |
| Staphylococcus aureus (ML 267) |
- |
- |
100 － ? |
Diospyros peregrina fruit (Methanol extract) |
682 |
| Staphylococcus aureus (ML 267) |
- |
- |
200 － ? |
Swietenia macrophylla bark (Methanol extract) |
682 |
| Staphylococcus aureus (ML15009 + penicillin-resistant) |
- |
- |
≤0.025 － ? |
Imipenem |
40 |
| Staphylococcus aureus (ML15009 + penicillin-resistant) |
- |
- |
≤0.025 － ? |
LJC 11036 |
40 |
| Staphylococcus aureus (ML15009 + penicillin-resistant) |
- |
- |
0.05 － ? |
Cefdinir (Omnicef, Cefdiel) |
40 |
| Staphylococcus aureus (ML15009 + penicillin-resistant) |
- |
- |
0.05 － ? |
Faropenem |
40 |
| Staphylococcus aureus (ML15009 + penicillin-resistant) |
- |
- |
0.2 － ? |
Levofloxacin (Levaquin, Quixin) |
40 |
| Staphylococcus aureus (ML15009/pI258 + penicillin-resistant) |
- |
- |
≤0.025 － ? |
Imipenem |
40 |
| Staphylococcus aureus (ML15009/pI258 + penicillin-resistant) |
- |
- |
≤0.025 － ? |
Imipenem |
40 |
| Staphylococcus aureus (ML15009/pI258 + penicillin-resistant) |
- |
- |
≤0.025 － ? |
LJC 11036 |
40 |
| Staphylococcus aureus (ML15009/pI258 + penicillin-resistant) |
- |
- |
0.05 － ? |
Cefdinir (Omnicef, Cefdiel) |
40 |
| Staphylococcus aureus (ML15009/pI258 + penicillin-resistant) |
- |
- |
0.2 － ? |
Levofloxacin (Levaquin, Quixin) |
40 |
| Staphylococcus aureus (moxifloxacin-intermediate) |
- |
- |
1 － ? |
Moxifloxacin (BAY 12-8039, Avelox) |
452 |
| Staphylococcus aureus (moxifloxacin-resistant) |
- |
- |
≥2 － ? |
Moxifloxacin (BAY 12-8039, Avelox) |
452 |
| Staphylococcus aureus (moxifloxacin-susceptible) |
- |
- |
≤0.5 － ? |
Moxifloxacin (BAY 12-8039, Avelox) |
452 |
| Staphylococcus aureus (MPR 5) |
- |
- |
0.06 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
434 |
| Staphylococcus aureus (MPR 5) |
- |
- |
0.25 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
451 |
| Staphylococcus aureus (MR5867) |
- |
- |
0.025 － ? |
Tosufloxacin |
135 |
| Staphylococcus aureus (MR5867) |
- |
- |
0.05 － ? |
Sparfloxacin (AT-4140, Zagam) |
135 |
| Staphylococcus aureus (MR5867) |
- |
- |
0.2 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
135 |